Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedThe revision label on the page changed to v3.6.3 from v3.6.2, indicating a small update to the document version.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a minor system update to the page. It does not alter the study content or user-facing functionality.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment status now shows No longer looking for participants; new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was standardized, and the footer revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page footer now shows Revision: v3.5.5 instead of v3.5.4, indicating a back-end/template update with no changes to the study content or core functionality.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a maintenance/version update to the page rather than changes to study information or functionality.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page footer’s software/site revision label was updated from v3.5.2 to v3.5.3, reflecting a minor platform maintenance change rather than any alteration to the study record content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.